Hypothesis testing: CTLA4 Co-stimulatory pathways critical in the pathogenesis of human and mouse alopecia areata

Journal of Investigative Dermatology

Volumn 131, Issue 11, 2011, Pages 2323-2324

  Sundberg, John P ^a,b   McElwee, Kevin J ^c   Carroll, Joseph M ^d   King Jr , Lloyd E ^b  

^a JACKSON LABORATORY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; IPILIMUMAB; MONOCLONAL ANTIBODY;

ALOPECIA AREATA; ANTIGEN BINDING; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; DRUG EFFICACY; GENE LOCUS; HUMAN; IMMUNOGENETICS; IMMUNOSTIMULATION; LETTER; MELANOMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 80054746199     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.203     Document Type: Letter

References (16)

1. Callahan MK, Wolchok JD, Allison JP (2010) Anti- CTLA-4 antibody therapy: immune monitoring during clinical development of a novel immunotherapy. Semin Oncol 37:473-84
2. Carroll J, McElwee KJ, King LE et al. (2002) Gene array profiling and immunomodulation studies define a cell mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans. J Invest Dermatol 119:392-402 (Pubitemid 35001949)
3. Dubois EA, Cohen AF (2009) Abatacept. Brit J Clin Pharmacol 68:480-1
4. John KK-G, Brockschmidt FF, Redler S et al. (2011) Genetic variants in CTLA4 are strongly associated with alopecia areata. J Invest Dermatol 131:1169-72
5. Moreland L, Bate G, Kirkpatrick P (2006) Abatacept. Nat Rev Drug Discov 5:185-6 (Pubitemid 43336031)
6. Petukhova L, Duvic M, Hordinsky M et al. (2010) Genome- wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 466:113-7
7. Subramanya RD, Coda AB, Sinha AA (2010) Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures. Genomics 96:146-53
8. Sun J, Silva KA, McElwee KJ et al. (2008) The C3H/ HeJ mouse and DEBR rat models for alopecia areata: preclinical drug screening tools. Exp Dermatol 17:793-805
9. Sundberg JP, Boggess D, Silva KA et al. (2003) Major locus on mouse chromosome 17 and minor locus on chromosome 9 are linked with alopecia areata in C3H/HeJ mice. J Invest Dermatol 120:771-5 (Pubitemid 36529076)
10. Sundberg JP, Cordy WR, King LE (1994) Alopecia areata in aging C3H/HeJ mice. J Invest Dermatol 102:847-56 (Pubitemid 24210378)
11. Sundberg JP, Schofield PN (2009) One medicine, one pathology, one health concept. J Am Vet Med Assoc 234:1530-1
12. Sundberg JP, Silva KA, Li R et al. (2004) Adult onset alopecia areata is a complex polygenic trait in the C3H/HeJ mouse model. J Invest Dermatol 123:294-7 (Pubitemid 38951823)
13. van der Worp HB, Howells DW, Sena ES et al. (2010) Can animal models of disease reliably inform human studies? PloS Med7:e1000245
14. Zoller M, McElwee KJ, Engel P et al. (2002) Transient CD44 variant isoform expression and reduction in CD4+/CD25+ regulatory T cells in C3H/HeJ mice with alopecia areata. J Invest Dermatol 118:983-92 (Pubitemid 34639176)
15. Zoller M, McElwee KJ, Vitacolonna M et al. (2004a) Apoptosis resistance in perifpheral blood lymphocytes of alopecia areata patients. J Autoimmunity 23:241-56 (Pubitemid 40288106)
16. Zoller M, McElwee KJ, Vitacolonna M et al. (2004b) The progressive state, in contrast to the stable or regressive state of alopecia areata, is reflected in peripheral blood mononuclear cells. Exp Dermatol 13:435-44 (Pubitemid 39077311)